Correction: Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation (PLoS ONE (2018) 13:4 (e0194803) DOI: 10.1371/journal.pone.0194803);Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation

PLoS ONE

Volumn 13, Issue 4, 2018, Pages

  Lee, Jungnam ^a   Arisi, Ivan ^b   Puxeddu, Ermanno ^c   Mramba, Lazarus K ^a   Amicosante, Massimo ^c   Swaisgood, Carmen M ^a   Pallante, Marco ^c   Brantly, Mark L ^a   Magnus Skold C ^d   Saltini, Cesare ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL2 CHEMOKINE; CXCL7 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IRON; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AGED; ANGIOGENESIS; ANIMAL CELL; ARTICLE; BASOPHIL; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; EX VIVO STUDY; FEMALE; FIBROSING ALVEOLITIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; IRON STORAGE; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE ACTIVATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; UPREGULATION; ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CYTOLOGY; GENE EXPRESSION PROFILING; MACROPHAGE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PHENOTYPE; SEQUENCE ANALYSIS;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INFLAMMATION; IRON; MACROPHAGES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; REACTIVE OXYGEN SPECIES; SEQUENCE ANALYSIS, RNA;

EID: 85045442541     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0197794     Document Type: Erratum

References (43)

1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183(6):788–824. https://doi.org/10.1164/rccm.2009-040GL PMID: 21471066.
2. Bringardner BD, Baran CP, Eubank TD, Marsh CB. The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal. 2008; 10(2):287–301. https://doi.org/10.1089/ars.2007.1897 PMID: 17961066.
3. Schupp JC, Binder H, Jager B, Cillis G, Zissel G, Muller-Quernheim J, et al. Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis. PLoS One. 2015; 10(1):e0116775. https://doi.org/10.1371/journal.pone.0116775 PMID: 25590613.
4. Foster MW, Morrison LD, Todd JL, Snyder LD, Thompson JW, Soderblom EJ, et al. Quantitative proteomics of bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. J Proteome Res. 2015; 14 (2):1238–49. https://doi.org/10.1021/pr501149m PMID: 25541672.
5. Capelli A, Di Stefano A, Gnemmi I, Donner CF. CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis. Eur Respir J. 2005; 25(4):701–7. https://doi.org/10.1183/09031936.05.00082604PMID: 15802346.
6. Keane MP, Belperio JA, Burdick MD, Lynch JP, Fishbein MC, Strieter RM. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001; 164(12):2239–42. https://doi.org/10.1164/ajrccm.164.12.2104106 PMID: 11751193.
7. Gibbons MA, MacKinnon AC, Ramachandran P, Dhaliwal K, Duffin R, Phythian-Adams AT, et al. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am J Respir Crit Care Med. 2011; 184(5):569–81. https://doi.org/10.1164/rccm.201010-1719OC PMID: 21680953.
8. Misharin AV, Morales-Nebreda L, Reyfman PA, Cuda CM, Walter JM, McQuattie-Pimentel AC, et al. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J Exp Med. 2017; 214(8):2387–404. https://doi.org/10.1084/jem.20162152 PMID: 28694385.
9. Kim KH, Maldonado F, Ryu JH, Eiken PW, Hartman TE, Bartholmai BJ, et al. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Res. 2010; 11:37. https://doi.org/10.1186/1465-9921-11-37 PMID: 20398288.
10. Colombat M, Mal H, Groussard O, Capron F, Thabut G, Jebrak G, et al. Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: Histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics. Hum Pathol. 2007; 38(1):60–5. https://doi.org/10.1016/j.humpath.2006.06.007 PMID: 16949908.
11. Magro CM, Waldman WJ, Knight DA, Allen JN, Nadasdy T, Frambach GE, et al. Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies. Hum Immunol. 2006; 67(4–5):284–97. https://doi.org/10.1016/j.humimm.2006.02.026 PMID: 16720208.
12. Puxeddu E, Comandini A, Cavalli F, Pezzuto G, D’Ambrosio C, Senis L, et al. Iron laden macrophages in idiopathic pulmonary fibrosis: the telltale of occult alveolar hemorrhage? Pulm Pharmacol Ther. 2014; 28(1):35–40. https://doi.org/10.1016/j.pupt.2013.12.002 PMID: 24365112.
13. Fukihara J, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, et al. Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study. BMC Pulm Med. 2017; 17(1):30. https://doi.org/10.1186/s12890-017-0376-8 PMID: 28166761.
14. Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H, et al. An unrestrained proinflamma-tory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest. 2011; 121(3):985–97. https://doi.org/10.1172/JCI44490 PMID: 21317534.
15. Nieuwenhuizen L, Schutgens RE, Coeleveld K, Mastbergen SC, Roosendaal G, Biesma DH, et al. Hemarthrosis in hemophilic mice results in alterations in M1-M2 monocyte/macrophage polarization. Thromb Res. 2014; 133(3):390–5. https://doi.org/10.1016/j.thromres.2013.10.039 PMID: 24252538.
16. Kroner A, Greenhalgh AD, Zarruk JG, Passos Dos Santos R, Gaestel M, David S. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron. 2014; 83(5):1098–116. https://doi.org/10.1016/j.neuron.2014.07.027 PMID: 25132469.
17. Sangiuolo F, Puxeddu E, Pezzuto G, Cavalli F, Longo G, Comandini A, et al. HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis. Eur Respir J. 2015; 45(2):483–90. https://doi.org/10.1183/09031936.00104814 PMID: 25504993.
18. Pezzuto G, Claroni G, Puxeddu E, Fusco A, Cavalli F, Altobelli S, et al. Structured multidisciplinary discussion of HRCT scans for IPF/UIP diagnosis may result in indefinite outcomes. Sarcoidosis Vasc Diffuse Lung Dis. 2015; 32(1):32–6. PMID: 26237353.
19. Ley B, Bradford WZ, Weycker D, Vittinghoff E, du Bois RM, Collard HR. Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis. Eur Respir J. 2015; 45(5):1374–81. https://doi.org/10.1183/09031936.00146314 PMID: 25614172.
20. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012; 185(9):1004–14. https://doi.org/10.1164/rccm.201202-0320ST PMID: 22550210.
21. Golde DW, Drew WL, Klein HZ, Finley TN, Cline MJ. Occult pulmonary haemorrhage in leukaemia. Br Med J. 1975; 2(5964):166–8. PMID: 1125726.
22. Ren P, Rosas IO, Macdonald SD, Wu HP, Billings EM, Gochuico BR. Impairment of alveolar macrophage transcription in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007; 175(11):1151–7. https://doi.org/10.1164/rccm.200607-958OC PMID: 17332483.
23. Jackson AF, Williams A, Moffat I, Phillips SL, Recio L, Waters MD, et al. Preparation of archival formalin-fixed paraffin-embedded mouse liver samples for use with the Agilent gene expression microarray platform. J Pharmacol Toxicol Methods. 2013; 68(2):260–8. https://doi.org/10.1016/j.vascn.2013.02. 008 PMID: 23458726.
24. Ishii T, Wallace AM, Zhang X, Gosselink J, Abboud RT, English JC, et al. Stability of housekeeping genes in alveolar macrophages from COPD patients. Eur Respir J. 2006; 27(2):300–6. https://doi.org/10.1183/09031936.06.00090405 PMID: 16452584.
25. Risso D, Ngai J, Speed TP, Dudoit S. Normalization of RNA-seq data using factor analysis of control genes or samples. Nat Biotechnol. 2014; 32(9):896–902. https://doi.org/10.1038/nbt.2931 PMID: 25150836.
26. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Research. 2000; 28(1):27–30. https://doi.org/10.1093/nar/28.1.27 PMID: 10592173
27. Alexa A, Rahnenfuhrer J, Lengauer T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics. 2006; 22(13):1600–7. https://doi.org/10.1093/bioinformatics/btl140 PMID: 16606683.
28. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, et al. A systems biology approach for pathway level analysis. Genome Res. 2007; 17(10):1537–45. https://doi.org/10.1101/gr.6202607 PMID: 17785539.
29. Becker M, De Bastiani MA, Parisi MM, Guma FT, Markoski MM, Castro MA, et al. Integrated Transcrip-tomics Establish Macrophage Polarization Signatures and have Potential Applications for Clinical Health and Disease. Sci Rep. 2015; 5:13351. https://doi.org/10.1038/srep13351 PMID: 26302899.
30. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014; 40(2):274–88. https://doi.org/10.1016/j.immuni.2014.01.006 PMID: 24530056.
31. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4):402–8. https://doi.org/10.1006/meth.2001. 1262 PMID: 11846609.
32. Strieter RM, Gomperts BN, Keane MP. The role of CXC chemokines in pulmonary fibrosis. J Clin Invest. 2007; 117(3):549–56. https://doi.org/10.1172/JCI30562 PMID: 17332882.
33. Ghio AJ, Pritchard RJ, Dittrich KL, Samet JM. Non-heme (Fe3+) in the lung increases with age in both humans and rats. J Lab Clin Med. 1997; 129(1):53–61. PMID: 9011591.
34. Thompson AB, Bohling T, Heires A, Linder J, Rennard SI. Lower respiratory tract iron burden is increased in association with cigarette smoking. J Lab Clin Med. 1991; 117(6):493–9. PMID: 2045717.
35. Persson HL, Vainikka LK, Eriksson HB, Wennerstrom U. Lane-Hamilton syndrome: ferritin protects lung macrophages against iron and oxidation. Chest. 2011; 139(2):361–7. https://doi.org/10.1378/chest.10-0818 PMID: 20705801.
36. Wijnen PA, Verschakelen JA, Bast A, Bekers O, Drent M. Diffuse alveolar hemorrhage in coumarin users: a fibrosing interstitial pneumonia trigger? Lung. 2013; 191(1):53–9. https://doi.org/10.1007/ s00408-012-9436-2 PMID: 23149804.
37. Montani D, Price LC, Dorfmuller P, Achouh L, Jais X, Yaici A, et al. Pulmonary veno-occlusive disease. Eur Respir J. 2009; 33(1):189–200. https://doi.org/10.1183/09031936.00090608 PMID: 19118230.
38. Oda K, Ishimoto H, Yamada S, Kushima H, Ishii H, Imanaga T, et al. Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis. Respir Res. 2014; 15:109. https://doi.org/10.1186/s12931-014-0109-y PMID: 25176016.
39. Cloonan SM, Mumby S, Adcock IM, Choi AMK, Chung KF, Quinlan GJ. The "Iron"-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017; 196 (9):1103–12. https://doi.org/10.1164/rccm.201702-0311PP PMID: 28410559.
40. Olakanmi O, McGowan SE, Hayek MB, Britigan BE. Iron sequestration by macrophages decreases the potential for extracellular hydroxyl radical formation. J Clin Invest. 1993; 91(3):889–99. https://doi.org/10.1172/JCI116310 PMID: 8383703.
41. Philippot Q, Deslee G, Adair-Kirk TL, Woods JC, Byers D, Conradi S, et al. Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary disease. PLoS One. 2014; 9(5):e96285. https://doi.org/10.1371/journal.pone.0096285 PMID: 24789352.
42. van der Schoot GGF, Westerink NL, Lubberts S, Nuver J, Zwart N, Walenkamp AME, et al. Variation in the HFE gene is associated with the development of bleomycin-induced pulmonary toxicity in testicular cancer patients. Eur J Cancer. 2016; 59:134–41. https://doi.org/10.1016/j.ejca.2016.02.013 PMID: 27033261.
43. Zamboni P, Izzo M, Tognazzo S, Carandina S, De Palma M, Catozzi L, et al. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radic Biol Med. 2006; 40 (10):1869–73. https://doi.org/10.1016/j.freeradbiomed.2006.01.026 PMID: 16678024.